Inventors:
Jay Harper - Clarksburg MD, US
Scott M. Lonning - Northbridge MA, US
Frank James Hsu - Wellesley MA, US
International Classification:
A61K 39/395, A61P 31/00, A61P 35/04, A61K 31/7068, A61P 35/00
US Classification:
4241331, 514 49, 4241581, 4241451
Abstract:
The invention provides compositions and methods for treating breast cancer. Specifically, the invention relates to administering a Transforming Growth Factor beta (TGFβ) antagonist in combination with capecitabine and ixabepilone to treat breast cancer.